IL6 and neoplasm: Additional analysis of the tumor microenvironment based on the expression of CD8+ T and PD-L1 showed that the high Compared to the low IL-6 group, the IL-6 group had a reduced percentage of type I (PD-L1+TILs+) tumors (P=0.012, Figure 4D).